Anna García-Altés
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anna García-Altés has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Mercè Barenys
Unitat de Digestiu, Hospital de Viladecans, Barcelona, Spain
2 shared publications- Salvador Peiró
Health Services Research Unit, Foundation for the Promotion of Health and Biomedical Research of València Region (FISABIO), 46020 València, Spain
2 shared publications Agueda Abad
1 shared publicationC Tebé
1 shared publicationC. Morant-Ginestar
1 shared publication- Daniel Santín
Complutense University of Madrid
1 shared publication
Latest Publications
- 1 November 2011
- Published by Elsevier in Value in Health
- Vol. 14 (7) , A347
PHP79 What Are the Research Priorities in the Spanish National Health System? A Comparison of Economic Evaluations of Health Care Interventions and Public-Funded Research
- 1 November 2011
- Published by Elsevier in Value in Health
- Vol. 14 (7) , A347
PHP79 What Are the Research Priorities in the Spanish National Health System? A Comparison of Economic Evaluations of Health Care Interventions and Public-Funded Research
- 30 June 2011
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 53 (6) , 1754-1755
A Systematic Review of Cost-effectiveness Evidence of Endoscopic Saphenous Vein Harvesting: Is it Efficient?
- 30 June 2011
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 53 (6) , 1754-1755
A Systematic Review of Cost-effectiveness Evidence of Endoscopic Saphenous Vein Harvesting: Is it Efficient?
- 1 June 2011
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 41 (6) , 831-836
A Systematic Review of Cost-effectiveness Evidence of Endoscopic Saphenous Vein Harvesting: Is it Efficient?
- 1 June 2011
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 41 (6) , 831-836
A Systematic Review of Cost-effectiveness Evidence of Endoscopic Saphenous Vein Harvesting: Is it Efficient?
- Open Access
- 23 May 2011
- Published by Springer Nature in BMC Health Services Research
- Vol. 11 (1) , 116
The evolution of health status and chronic conditions in Catalonia, 1994-2006: the paradox of health revisited using the Blinder - Oaxaca decomposition
The paradox of health refers to the improvement in objective measures of health and the increase in the reported prevalence of chronic conditions. The objective of this paper is to test the paradox of health in Catalonia from 1994 to 2006.
- 23 May 2011
- Published by Springer Nature in BMC Health Services Research
- Vol. 11 (1) , 116
Open AccessThe evolution of health status and chronic conditions in Catalonia, 1994-2006: the paradox of health revisited using the Blinder - Oaxaca decomposition
The paradox of health refers to the improvement in objective measures of health and the increase in the reported prevalence of chronic conditions. The objective of this paper is to test the paradox of health in Catalonia from 1994 to 2006.
- 1 March 2011
- Published by Wolters Kluwer Health in Journal of Trauma: Injury, Infection & Critical Care
- Vol. 70 (3) , 744-750
What Is the Social Cost of Injured People in Traffic Collisions? An Assessment for Catalonia
Traffic collisions are an important public health problem worldwide, in terms of mortality, morbidity, and economic burden. The goal of this study is to estimate the social cost of injured people in traffic collisions in Catalonia in the year 2007. We performed a cost-of-illness analysis, under the perspective of the healthcare system, the public sector, and the society, using a 1-year time horizon. In Catalonia, during 2007, there were a total of 26,063 collisions with victims, which translates into 34,565 non-mortal victims and 521 deaths. As direct costs, all healthcare costs (primary care, acute hospital care, emergency care, ambulances and transport, long-term care, and specialized care); costs of adaptation to disability, disability benefits, material costs, and administrative costs; and costs of police, fire-fighters, and road assistance have been included. As indirect costs, productivity losses as a result of hospital and long-term institutionalization as well as productivity losses from work sick leave and productivity losses of carers have been taken into account. From the perspective of the healthcare system, the cost of the injured people in traffic collisions was 31,803,024.03€ in 2007; from the perspective of the public sector, it was 134,047,059.27€ (up to 1,463,645,407.13€ in the sensitivity analysis) and 144,043,238.88€ (up to 1,558,926,995.12€ in the sensitivity analysis) from the perspective of the society. The cost per injured person ranged from 3,855.38€ from the perspective of the healthcare system to 17,461.90€ from the perspective of the society (up to 188,983.76€ in the sensitivity analysis). The importance of the costs of injured people in traffic collisions is an argument more—besides the epidemiologic and social impact—to start off preventive policies.
- 1 March 2011
- Published by Wolters Kluwer Health in Journal of Trauma: Injury, Infection & Critical Care
- Vol. 70 (3) , 744-750
What Is the Social Cost of Injured People in Traffic Collisions? An Assessment for Catalonia
Traffic collisions are an important public health problem worldwide, in terms of mortality, morbidity, and economic burden. The goal of this study is to estimate the social cost of injured people in traffic collisions in Catalonia in the year 2007. We performed a cost-of-illness analysis, under the perspective of the healthcare system, the public sector, and the society, using a 1-year time horizon. In Catalonia, during 2007, there were a total of 26,063 collisions with victims, which translates into 34,565 non-mortal victims and 521 deaths. As direct costs, all healthcare costs (primary care, acute hospital care, emergency care, ambulances and transport, long-term care, and specialized care); costs of adaptation to disability, disability benefits, material costs, and administrative costs; and costs of police, fire-fighters, and road assistance have been included. As indirect costs, productivity losses as a result of hospital and long-term institutionalization as well as productivity losses from work sick leave and productivity losses of carers have been taken into account. From the perspective of the healthcare system, the cost of the injured people in traffic collisions was 31,803,024.03€ in 2007; from the perspective of the public sector, it was 134,047,059.27€ (up to 1,463,645,407.13€ in the sensitivity analysis) and 144,043,238.88€ (up to 1,558,926,995.12€ in the sensitivity analysis) from the perspective of the society. The cost per injured person ranged from 3,855.38€ from the perspective of the healthcare system to 17,461.90€ from the perspective of the society (up to 188,983.76€ in the sensitivity analysis). The importance of the costs of injured people in traffic collisions is an argument more—besides the epidemiologic and social impact—to start off preventive policies.
- 30 November 2008
- Published by Elsevier in Value in Health
- Vol. 11 (6) , A432-A433
PIN15 COST-EFFECTIVENESS OF PALIVIZUMAB IN THE PROPHYLAXIS OF SEVERE BRONCHIOLITIS CAUSED BY RSV: RESULTS OF A DECISION MODEL WITH LOCAL DATA
- 30 November 2008
- Published by Elsevier in Value in Health
- Vol. 11 (6) , A432-A433
PIN15 COST-EFFECTIVENESS OF PALIVIZUMAB IN THE PROPHYLAXIS OF SEVERE BRONCHIOLITIS CAUSED BY RSV: RESULTS OF A DECISION MODEL WITH LOCAL DATA
- 1 August 2007
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 16 (4) , 331-346
Applying artificial neural networks to the diagnosis of organic dyspepsia
Background. Dyspepsia diagnoses and treatment decisions are made in situations in which multiple factors must be taken into account. Evolving from neuro-biological insights, artificial neural networks (ANNs) can employ multiple factors in resolving medical prediction, classification, pattern recognition, and pattern completion. The objective of this study was to compare predictive results classifying people with organic dyspepsia with Helicobacter pylori testing (rapid urease test), a scoring system based on patients' symptoms (derived using logistic regression), classification and regression trees (CART) and the most common ANN approach used in medicine: a feed-forward multilayer perceptron (MLP) trained by back-propagation. Methods. A scoring system, CART algorithm, and MLP model were constructed. Predictive accuracy was calculated for them and for Helicobacter pylori testing. Results. MLP model had a sensitivity of 0.91 (0.81 for all data) and a specificity of 0.74 (0.79 for all data) for test data. That compares favorably with Helicobacter pylori testing (sensitivity = 0.80, specificity = 0.43), the scoring system (sensitivity = 0.85, specificity = 0.60), and the CART model (sensitivity = 0.88, specificity = 0.53). Diagnostic accuracy, the area under the curve, was 0.82 using the MLP model, 0.61 using Helicobacter pylori testing, 0.78 using the scoring system, and 0.72 for the test set using CART. Conclusions. The results of the analysis showed that the ANN model derived has better predictive accuracy than Helicobacter pylori testing, than a scoring system based on patients' symptoms and than a decision tree algorithm (CART). ANN model could be used as a predictive tool for organic dyspepsia and would be useful in the process of referral of dyspeptic patients from primary care to endoscopy units.
- 1 August 2007
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 16 (4) , 331-346
Applying artificial neural networks to the diagnosis of organic dyspepsia
Background. Dyspepsia diagnoses and treatment decisions are made in situations in which multiple factors must be taken into account. Evolving from neuro-biological insights, artificial neural networks (ANNs) can employ multiple factors in resolving medical prediction, classification, pattern recognition, and pattern completion. The objective of this study was to compare predictive results classifying people with organic dyspepsia with Helicobacter pylori testing (rapid urease test), a scoring system based on patients' symptoms (derived using logistic regression), classification and regression trees (CART) and the most common ANN approach used in medicine: a feed-forward multilayer perceptron (MLP) trained by back-propagation. Methods. A scoring system, CART algorithm, and MLP model were constructed. Predictive accuracy was calculated for them and for Helicobacter pylori testing. Results. MLP model had a sensitivity of 0.91 (0.81 for all data) and a specificity of 0.74 (0.79 for all data) for test data. That compares favorably with Helicobacter pylori testing (sensitivity = 0.80, specificity = 0.43), the scoring system (sensitivity = 0.85, specificity = 0.60), and the CART model (sensitivity = 0.88, specificity = 0.53). Diagnostic accuracy, the area under the curve, was 0.82 using the MLP model, 0.61 using Helicobacter pylori testing, 0.78 using the scoring system, and 0.72 for the test set using CART. Conclusions. The results of the analysis showed that the ANN model derived has better predictive accuracy than Helicobacter pylori testing, than a scoring system based on patients' symptoms and than a decision tree algorithm (CART). ANN model could be used as a predictive tool for organic dyspepsia and would be useful in the process of referral of dyspeptic patients from primary care to endoscopy units.
- 1 July 2005
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 17 (7) , 709-719
Cost-effectiveness of a ???score and scope??? strategy for the management of dyspepsia
It is important to identify the best initial work-up in patients with uninvestigated dyspepsia because of its epidemiological and economical relevance. The objective of the study was to assess systematically the effectiveness and cost-effectiveness of invasive and non-invasive strategies for the management of dyspepsia. A decision analysis was performed to compare prompt endoscopy, score and scope, test and scope, test and treat, and empirical antisecretory treatment. Published and local data on the prevalence of different diagnoses, rates of Helicobacter pylori infection, accuracy values of diagnostic tests, and effectiveness of drug treatments were used. The perspective of analysis was that of the public healthcare payer, and only direct costs were included, with a one-year post-therapy time horizon. The main outcome measure was cost per asymptomatic patient, valued in 2003 Euros. Endoscopy was found to be the most effective strategy for the management of dyspepsia (38.4% asymptomatic patients), followed by test and scope (35.5%), test and treat (35.3%), score and scope (34.7%), and empirical treatment (28.5%). Incremental cost-effectiveness ratios showed that score and scope was the most cost-effective alternative (483.17 Euros per asymptomatic patient), followed by prompt endoscopy (1396.85 Euros). Sensitivity analyses showed variations when varying the values of prevalence of duodenal ulcer, and the values of healing of functional dyspepsia with antisecretory and eradication drugs. There were no changes when varying the prevalence of H. pylori in dyspepsia. We would recommend stratifying patients by a score system, referring first to endoscopy those patients at higher risk of organic dyspepsia.
- 1 July 2005
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 17 (7) , 709-719
Cost-effectiveness of a ???score and scope??? strategy for the management of dyspepsia
It is important to identify the best initial work-up in patients with uninvestigated dyspepsia because of its epidemiological and economical relevance. The objective of the study was to assess systematically the effectiveness and cost-effectiveness of invasive and non-invasive strategies for the management of dyspepsia. A decision analysis was performed to compare prompt endoscopy, score and scope, test and scope, test and treat, and empirical antisecretory treatment. Published and local data on the prevalence of different diagnoses, rates of Helicobacter pylori infection, accuracy values of diagnostic tests, and effectiveness of drug treatments were used. The perspective of analysis was that of the public healthcare payer, and only direct costs were included, with a one-year post-therapy time horizon. The main outcome measure was cost per asymptomatic patient, valued in 2003 Euros. Endoscopy was found to be the most effective strategy for the management of dyspepsia (38.4% asymptomatic patients), followed by test and scope (35.5%), test and treat (35.3%), score and scope (34.7%), and empirical treatment (28.5%). Incremental cost-effectiveness ratios showed that score and scope was the most cost-effective alternative (483.17 Euros per asymptomatic patient), followed by prompt endoscopy (1396.85 Euros). Sensitivity analyses showed variations when varying the values of prevalence of duodenal ulcer, and the values of healing of functional dyspepsia with antisecretory and eradication drugs. There were no changes when varying the prevalence of H. pylori in dyspepsia. We would recommend stratifying patients by a score system, referring first to endoscopy those patients at higher risk of organic dyspepsia.